The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
What Is The Expected Market Size Of The Veterinary Active Pharmaceutical Ingredients Manufacturing Market In 2026 And How Much Will It Reach By 2030?
The veterinary active pharmaceutical ingredients manufacturing market has shown substantial growth in recent years. Its size is expected to climb from $8.03 billion in 2025 to $8.71 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 8.5%. Key drivers for this historical expansion include the increasing prevalence of animal diseases, the rising populations of livestock and companion animals, the expanding veterinary pharmaceutical industry, the development of conventional chemical-based APIs, and a growing demand for anti-infective and antiparasitic drugs.
The veterinary active pharmaceutical ingredients manufacturing market size is set to experience substantial growth over the next few years. It is anticipated to expand to $12.06 billion by 2030, achieving a compound annual growth rate (CAGR) of 8.5%. This projected expansion can be linked to the increased adoption of biological and recombinant APIs, a rise in contract manufacturing services, the surging demand for highly potent APIs, favorable regulatory support for veterinary pharmaceutical production, and an escalating focus on vaccine API innovations. Key trends during the forecast period include the growth of contract manufacturing for veterinary APIs, the development of highly potent APIs, an expansion of in-house API production capabilities, a heightened emphasis on anti-infective and antiparasitic APIs, and ongoing innovation in vaccine API formulations.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7942&type=smp
Which Strategic Drivers Are Supporting The Veterinary Active Pharmaceutical Ingredients Manufacturing Market Development?
The increasing prevalence of zoonotic diseases is expected to propel the growth of the veterinary active pharmaceutical ingredients manufacturing market going forward. A zoonotic disease, also known as zoonosis, is an infectious disease that can be transmitted naturally from animals to humans or from humans to animals. Zoonotic diseases are rising because increased human–animal interaction creates more opportunities for pathogens to spread from animals to people and establish new infections. Veterinary APIs are used in the development of vaccines that can prevent the spread of zoonotic diseases from animals to humans. The use of veterinary APIs can also help prevent antibiotic resistance, which is a major concern in the treatment of zoonotic diseases. For instance, in February 2023, according to the Council on Foreign Relations (CFR), a US-based independent, nonpartisan member organization, think tank, and publisher, up to 75% of newly discovered or emerging infectious diseases (EIDs) and 60% of recognized infectious diseases had zoonotic origins. Worldwide, zoonoses cause 2.7 million human fatalities and 2.5 billion episodes of disease in people each year. Therefore, the increasing prevalence of zoonotic diseases is driving the growth of the veterinary active pharmaceutical ingredients manufacturing market.
What Are The Core Segment Classifications In The Veterinary Active Pharmaceutical Ingredients Manufacturing Market?
The veterinary active pharmaceutical ingredients manufacturing market covered in this report is segmented –
1) By Product: Antiparasitic, Anti-Infectives, Vaccines, NSAIDs
2) By Service Type: In House, Contract Outsourcing
3) By Synthesis Type: Chemical Based API, Biological API, Highly Potent API
Subsegments:
1) By Antiparasitic: Endectocides, Anthelmintics, Antiprotozoals
2) By Anti-Infectives: Antibiotics, Antifungals, Antivirals
3) By Vaccines: Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines
4) By Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Non-Selective NSAIDs, COX-2 Inhibitors
Which Trends Are Shaping The Veterinary Active Pharmaceutical Ingredients Manufacturing Market Landscape?
Major companies operating in the veterinary active pharmaceutical ingredient manufacturing market are focused on introducing manufacturing plants for APIs to gain a competitive edge in the market. Manufacturing plants for veterinary APIs are facilities that produce active pharmaceutical ingredients used in the formulation of veterinary drugs. For instance, in October 2023, Stallen South Asia Private Limited, an India-based animal health company, launched, unveiled, and started operations at a new veterinary API facility for Halquinol, a non-antibiotic growth promoter belonging to a group of hydroxyquinolines. It is a combination of 5-chloro-8-hydroxyquinoline, 5,7-dichloro-8-hydroxyquinoline, and 7-chloro-8-hydroxyquinoline. Produced products include Halquinol 98%, which is manufactured in accordance with British Pharmacopeia 1980 (BP 80) guidelines. In addition to the more typical 60% and 12%, Stallenis is able to sell 98% as a chemical API used in veterinary formulations and feed additives. Stallen wants to lessen the reliance on goods coming from China for the animal health industry by gradually introducing a wide range of APIs from this plant.
Which Companies Are Engaged In The Veterinary Active Pharmaceutical Ingredients Manufacturing Market Environment?
North America was the largest region in the veterinary active pharmaceutical ingredients manufacturing market in 2025. The regions covered in the veterinary active pharmaceutical ingredients manufacturing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access The Complete Veterinary Active Pharmaceutical Ingredients Manufacturing Market Report:
Which Region Leads The Veterinary Active Pharmaceutical Ingredients Manufacturing Market By Size?
North America was the largest region in the veterinary active pharmaceutical ingredients manufacturing market in 2025. The regions covered in the veterinary active pharmaceutical ingredients manufacturing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access a Customized Veterinary Active Pharmaceutical Ingredients Manufacturing Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/sample.aspx?id=7942&type=smp
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model